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ackground: Anesthetics are responsible for imparting many effects on the central nervous system. 
We hypothesized that short duration anesthetics may have varied effects at different time of the 
day. Propofol (short duration anaesthesia) has showed circadian variation in loss of righting reflex 
during 24 hours of the day. 
Methods: Characterization of the effects of propofol anaesthesia on ERK1/2 in hippocampus at two 
different times of the day was performed. Male rats received either an intra-peritoneal injection of 120 
mg/kg of propofol to set short-duration anaesthesia state (20-30 minutes) or the equivalent amount of the 
lipidic solvent as controls. For both groups of animals, anaesthesia or control, the injections were 
performed either at ZT0 or at ZT12. One hour following the injection, the animals were euthanized; the 
brains were removed and immediately frozen. The amount of ERK1/2 was assessed by using 
immunohistochemistry on brain sections. 
Results: The amount of ERK1/2 density was significantly decreased (P<0.05) in CA1, CA2 and CA3 areas 
of the hippocampus only when anaesthesia was performed at ZT12.  
Conclusion: Our current results evidenced that the impact of propofol anaesthesia on hippocampus vary 
depending on the zeitgeber time.  
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Introduction  
Propofol (2, 6-diisopropylphenol) is a highly effective IV 
anaesthetic and is widely used for general anaesthesia 
and for sedation with local anaesthesia [1,2].  Propofol 
produces rapid sedation with quick onset and offset and 
relatively few serious side effects (bradycardia, 
hypotension and dose-dependent respiratory 
depression). Propofol induced amnesia could be 
observed not only at low dose under its administration 
in both animal models and in human volunteers but also 
at recovery from anaesthesia [3,4]. The detailed 
mechanisms underlying the amnesic effect of propofol 
are still under examination. The amnesic effect of 
propofol is considered to be related to an inhibition of 
long term potentiation (LTP) at Schaffer collateral-
commissural pathway to CA1 (Cornu Ammonis area) 
pyramidal cell synapses in the hippocampus [5-7]. 
Neuroscientists generally agree that the hippocampus 
has an important role in the formation of new memories 
about experienced events (episodic or autobiographical 
memory) and consolidation [8,9]. 
Several behavioral and cellular studies show that 
Extracellular Signal–Regulated Kinase 1/2 (ERK1/2) has 
a very important role in controlling Long-term 
potentiation (LTP) and memory formation in the adult 
brain [10-12]. ERK1/2 activation facilitates 
transcriptional events and as a result, it regulates 
distribution and functions of synaptic proteins to 
control many forms of synaptic plasticity, including LTP 
and memory in the hippocampus [5,6]. A concentration 
dependent increase was seen in both the membrane and 
cytosolic fractions of cortical cells in culture; these 
changes in ERK1/2 phosphorylation being induced by 
the binding of propofol to the GABAAR (Gama amino 
butyric acid type A receptor) complex [13]. Propofol has 
showed circadian effect for its hypnotic properties in 
rats [14]. Is there any effect of propofol on ERK1/2 at 
different zeitgeber times? 
The goal of the study was to examine the effect of in 
vivo administration of propofol on ERK1/2 protein in 
the hippocampus at two different zeitgeber times; ZT0 
(start of rest period) and ZT12 (start of activity period). 
For this, we used an ex-vivo technique, the 
immunostaining of ERK1/2 on brain sections collected 
one hour after the injection of propofol.  
Methods 
Male rats of 8 weeks (Long Evans, Charles River) were 
housed in 22-24°C and they were kept in 12:12 hours 
light–dark cycle with ad libitum for 15 days before the 
experiments. Propofol (Propofol Fresenius®1% 
manufactured by Fresenius Kabi, France) or the lipidic 
solvent Intralipid (Intralipid® manufactured by 
Fresenius Kabi, France) as a control were given intra 
peritoneally at the dose of 120mg/kg at ZT0 and ZT12. 
Animals were euthanized by exposure of carbon 
dioxide; the brains were quickly removed on ice and 
frozen in isopentane at -40°C. Sequential 25 m-thick 
brain coronal sections were cut at -18°C on a cryostat at 
-3.14 coordinate from bregma according to the atlas of 
Paxinos et al. [15] (Fig 3). 
Briefly, immunohistochemistry steps were carried out 
at room temperature (18-22°C) unless otherwise 
specified. All washes were carried out under gentle 
agitation for ten minutes and repeated three times in 
buffer, 0.02M TBS (Tris Buffer Saline). Incubations were 
carried out on flat slides in humid chambers and 400-
500 µL of reagent was provided per each slide depending 
upon the surface area of the tissues. Tissues were fixed 
in 4% paraformaldehyde for seven minutes. After being 
fixed by the paraformaldehyde, slides were placed in 
0.3% hydrogen peroxide diluted in 50 mL TBS for 15 
minutes to quench endogenous peroxidases. Slides were 
incubated for 1 hour in 5% goat serum (Vector Lab 
Birlingame CA USA), then incubated in rabbit 
phosphorylated ERK1/2 antibody (Cell Signalling 
Technology California USA, Cat # 9102) to measure the 
total ERK1/2, in the dilution ratio1:500 overnight at 4°C. 
The secondary antibody was anti-rabbit made in goat 
(Vector Lab Birlingame CA USA, Cat # AP-1000). 
Sections were incubated with Avidine–Biotin peroxides 
complex (Vectastain Elite Kit, Vector Laboratories). 
Both Avidin-Biotins were used as 3 µL per mL of TBS 
0.01%. Sections were stained with a chromagen DAB (3, 
3- diaminobenzidine tetrahydrochloride by company 
SIGMA, Missouri USA), then sections were dehydrated 
and cover slipped.  
The variable examined was the total ERK1/2 
immunostaining per µm2. For each area, a global two 
way analysis of variance (ANOVA) was performed, 
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between factors and time: ZT0 versus ZT12 and 
treatment: Intralipids versus Propofol. If a significant 
effect was observed, post hoc analyses were performed 
using a t-test with Bonferonni correction for multiple 
comparisons (Systat 8.0 software). 
All the experiments on rats were performed as per 
approved guidelines and with the prior approval of the 
University Advanced Research Board, INSERM U666, 
University of Strasbourg, France. 
Results 
These rats were divided into four groups on the basis of 
treatment and time of administration (n=6 per group). 
Following the injection of propofol, all animals lost their 
righting reflex in a 5-8 minutes delay. The mean time in 
minutes for ZT0 and ZT12 to recover the righting reflex 
following the injection of propofol was 28 and 35 
respectively. One hour after the injection, all animals 
have recovered not only their righting reflex but also 
their spontaneous locomotion. 
ANOVA in CA1 area of the hippocampus 
demonstrated that there are significant effects of 
treatment (F (1, 12) =25.88, P<10-4) and time (F (1.12) 
=7.48, P=0.017) with a significant interaction between 
treatment and time on the ERK1/2 immunostaining in 
CA1 area of the hippocampus (Fig 2). Indeed post hoc 
analysis revealed that there are significant differences 
only at ZT12, intralipid versus propofol (P=0.03) and for 
propofol, ZT0 versus ZT12 (P=0.05). General analysis of 
variance in CA2 area demonstrated that there are a 
significant effect of treatment (F (1, 12) =17.84, P<10-4) 
and no effect of time (F (1.13) =2.13, P=0.167) on the 
ERK1/2 immunostaining in CA2 area of the 
hippocampus. Indeed post hoc analysis revealed that 
there is a significant difference only at ZT12, intralipid 
versus propofol (P=0.03) and a marginal effect for ZT0 
versus ZT12 in the propofol group (P=0.057). There is 
similar significant effects of treatment (F (1. 12) =9.61, 
P=0.003) and no effect of time (F (1.12) =1.232, =0.287) 
on the ERK1/2 immunostaining in CA3 area of the 
hippocampus. Indeed post hoc analysis revealed that 
there is a significant difference only at ZT12, intralipid 
versus propofol (P=0.014) and a marginal effect for ZT0 
versus ZT12 in the propofol group (P=0.107). There is 
no significant effect of treatment (F (1, 12) =2.48, 
P=0.141) but a significant effect of time (F (1.12) =7.139, 
P=0.020) on the ERK1/2 immunostaining in DG area of 
the hippocampus (Fig.1). 
 
Figure 1: Effects of propofol and the lipidic solvent (Intralipids) on 
ERK1/2 immunostaining in CA1, CA2, CA3 and Dentate Gyrus (DG) 
areas of hippocampus at the two different circadian times (ZT0, and 
ZT12, offset and onset of activity period respectively). *means P<0.05 
 
Figure 2: ERK1/2 immunostaining in different hippocampal areas 
with propofol and intralipid treatments here yellow, green, red and 
black circles represent CA1, CA2, CA3 and DG respectively. 
 
Figure 3: Diagrams of coronal sections indicating areas sampled. The 
numbers indicate the distance in millimeters of the sections from the 
bregma. 
Discussion  
In the present study, we observed the effect of propofol 
on ERK1/2 protein at two different zeitgeber times (ZT0 
and ZT12). Our main results show remarkable decrease 
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in the ERK1/2 protein at ZT12 in hippocampal areas 
(CA1, CA2 and CA3) without any change in the DG 
induced by propofol. However, we find significant 
difference at ZT0 and ZT12 for the control situation 
(Intralipids). No anesthetic effect at ZT12 may be due to 
the fact that DG has high density of neurons and is one 
of the brain structures with high rates of neurogenesis in 
the adult rats [16]. It is also observed that DG neurons 
born prenatally as well as postnatal, in contrast 
hippocampal neurons born prenatally [17]. There may 
anesthetic effect with large dose and or long duration 
anesthetics. Effect of zeitgeber time on general 
anesthetics can be of clinical importance, resulting in 
alteration of circadian and biological rhythms and might 
be responsible for sleep disorders as an increase in 
sleepiness, drowsiness and a decrease in vigilance [18]. 
Previous studies have shown that propofol may 
disturb the ERK1/2. A concentration-dependent 
increase of ERK-1/2 phosphorylation in the brain has 
been observed. This increase being blocked by a GABA 
antagonist, suggesting that the observed changes in 
ERK-1/2 phosphorylation were induced by the binding 
of propofol to the GABAAR complex [13]. Conversely, 
in cultured rat hippocampal neurons, propofol reduced 
the N-methyl-D-aspartate receptor (NMDAR) 
dependent activation of MAPK/ERK cascade [19]. 
NMDA receptors are phosphorylated at Ser897 and 
Ser896 positions and these sites for phosphorylation are 
blocked by propofol [20]. Therefore, it has been 
suggested that propofol may affect NMDAR–dependent 
ERK phosphorylation by affecting NMDA 
phosphorylation [7]. Our results obtained at recovery 
from anaesthesia are in accordance with those obtained 
in vivo by Kozinn et al [21]. It is an evidence of a long 
lasting inhibitory effect of propofol on ERK1/2 
phosphorylation in hippocampus which is contrasting 
with the results obtained by Oscarson et al. [22] in brain 
cell culture. However, the methodology used in this last 
study differs largely from our study. Firstly, we 
examined the ERK1/2 contents at recovery from 
anesthesia, one hour after propofol administration while 
Orscarson examined ERK1/2 phosphorylation soon 
after the administration of propofol at concentration 
clinically relevant for an anesthesia state. 
Decrease of hippocampal ERK1/2, appears to us 
important to understand the cellular mechanisms 
underlying the well described inhibitory effect of 
propofol on LTP and probably its amnesic effect. 
Indeed, a significant contribution of ERK1/2 
phosphorylation to synaptic plasticity and memory 
formation in the adult brain has been established in 
behavioral as well as in cellular studies [11,23]. ERK1/2 
is required for the induction of stable LTP while LTP 
inducing high frequency stimulation of schaffer- 
collateral inputs to area CA1 lead to the activation of 
ERK1/2 in CA1 [24]. Such a role of activation of ERK1/2 
in memory has also been observed in vivo; the 
performance in a fear learning task in rodents being 
largely decreased when animals received Methyl ethyl 
ketone (MEK) inhibitors while, fear learning was 
associated with a significant activation of ERK1/2 in 
hippocampus in trained animals [25]. As mentioned 
above, propofol has amnesic effect at low dose, high 
anesthetic dose and at recovery from anesthesia [3,4]. 
The amnesic effect of propofol is considered to be 
related to its known inhibition of LTP at Schaffer 
collateral-commissural pathway to CA1 pyramidal cell 
synapses in the hippocampus [5-7]. From our results, we 
can suggest that a specific inhibitory effect of propofol 
on ERK1/2 in hippocampus might be one of the 
transcriptional targets to explain the inhibitory effect of 
propofol on hippocampal LTP. 
Our results focusing on hippocampus evidenced 
clearly, and for the first time to our knowledge, that 
propofol has an inhibitory effect on ERK1/2 and that 
this inhibitory effect depends on the time of the day 
administration of propofol. Propofol is known to have 
inhibitory effect on hippocampal long term potentiation 
and memory. Our first results open a line of researches 
to understand the detailed cellular mechanisms involved 
in the memory effects of propofol, more particularly at 
recovery from anaesthesia. 
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